Hydrogel Matrix Entrapping PLGA-Paclitaxel Microspheres: Drug Delivery with Near Zero-Order Release and Implantability Advantages for Malignant Brain Tumour Chemotherapy

PurposeTo develop paclitaxel-delivering PLGA microspheres entrapped in a gel matrix with sustained drug release properties and implantability advantages for local glioma chemotherapy.MethodsPaclitaxel-loaded PLGA microspheres were fabricated using electrohydrodynamic atomization and entrapped by electrospray and gelation. The physicochemical characterizations were performed using scanning electron microscopy and differential scanning calorimetry. The influence of various parameters on the disintegration time was investigated. In vitro release of paclitaxel was quantified using high performance liquid chromatography. Cytotoxicity of the formulations was assessed by the quantification of IC50 and caspase-3 activity against C6 glioma cells in vitro. The formulations were tested against a subcutaneous C6 glioma tumour in mice.ResultsHighly monodisperse gel beads containing a uniform microsphere distribution were obtained. Gelation using Ca2+ ions ensured entrapment of microspheres with high loading efficiency. With an increase in the gelation time, gelling bath concentration and decrease in microsphere loading, it was more difficult to disintegrate the beads and release the microspheres. The formulations demonstrated sustained drug release for more than 60 days at a near-constant rate and a low initial burst. Cell culture studies proved the cytotoxicity against C6 glioma and improved performance in comparison to Taxol®. The formulations could reduce subcutaneous tumour volume to a greater extent compared to Taxol® and the control.ConclusionsPaclitaxel-loaded PLGA microspheres entrapped in an alginate gel matrix could be potential local chemotherapy implants to treat malignant glioma with critical advantages of implantability and sustained drug release with low initial burst.

[1]  P. Burger,et al.  Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. , 1994, Cancer research.

[2]  M. Chamberlain,et al.  Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas. , 1999, Archives of neurology.

[3]  H. Brem,et al.  Polymers to treat brain tumours. , 1990, Biomaterials.

[4]  Chi-Hwa Wang,et al.  Electrospray in the dripping mode for cell microencapsulation. , 2007, Journal of colloid and interface science.

[5]  S. Prakash,et al.  Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy , 2007, Cell Biochemistry and Biophysics.

[6]  J. Olson,et al.  Carboplatin-Loaded PLGA Microspheres for Intracerebral Implantation: In Vivo Characterization. , 1997, Drug delivery.

[7]  Anthony Atala,et al.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy , 2001, Nature Biotechnology.

[8]  A. Friedman,et al.  Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.

[9]  A. Göpferich,et al.  Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. , 2002, International journal of pharmaceutics.

[10]  M. Berger,et al.  Phase II study of paclitaxel in patients with recurrent malignant glioma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Xinguo Jiang,et al.  Aclarubicin‐loaded cationic albumin‐conjugated pegylated nanoparticle for glioma chemotherapy in rats , 2007, International journal of cancer.

[12]  Christine Kratzel,et al.  Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases , 2004, Journal of Neuro-Oncology.

[13]  C. Dubernet Thermoanalysis of microspheres , 1995 .

[14]  H. Brem,et al.  Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. , 2005, Anticancer research.

[15]  F. Vittur,et al.  Chondrocyte-alginate bioconstructs: a nuclear magnetic resonance relaxation study. , 2007, Journal of biomedical materials research. Part A.

[16]  Anthony Asher,et al.  A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme , 2005, Journal of Neuro-Oncology.

[17]  K. Walter,et al.  Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Z. Sellers,et al.  Calcium channel γ subunits: a functionally diverse protein family , 2007, Cell Biochemistry and Biophysics.

[19]  Fumiko Yonezawa,et al.  Glass Transition , 1990, Int. J. High Perform. Comput. Appl..

[20]  H. Brem,et al.  Local Delivery of Interleukin-2 and Adriamycin is Synergistic in the Treatment of Experimental Malignant Glioma , 2005, Journal of Neuro-Oncology.

[21]  E. Donth Relaxation and thermodynamics in polymers : Glass transition , 1992 .

[22]  Chi‐Hwa Wang,et al.  Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. , 2006, Biomaterials.

[23]  H. Choy,et al.  Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. , 1995, Journal of the National Cancer Institute.

[24]  J. Benoit,et al.  Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. , 1996, Neurosurgery.

[25]  J. Benoit,et al.  Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. , 2006, International journal of pharmaceutics.

[26]  W. Saltzman,et al.  Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. , 1998, Cancer research.

[27]  Henry Brem,et al.  Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers , 2004, Investigational New Drugs.

[28]  David J Mooney,et al.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.

[29]  M. Samii,et al.  Biopolymer-mediated suramin chemotherapy in the treatment of experimental brain tumours , 2004, Acta oncologica.

[30]  É. Cavalheiro,et al.  Thermal behavior of alginic acid and its sodium salt , 2004, Ecletica Quimica.

[31]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[32]  M. Chamberlain,et al.  AIDS-related Central Nervous System Lymphomas , 1999, Journal of Neuro-Oncology.

[33]  R. Müller,et al.  Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[34]  F. L. Fertonani,et al.  Application of differential scanning calorimetry in hair samples as a possible tool in Forensic Science , 2004, Ecletica Quimica.

[35]  Chi-Hwa Wang,et al.  Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel , 2005, Pharmaceutical Research.

[36]  Chi-Hwa Wang,et al.  Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. , 2008, Biomaterials.

[37]  M. Chamberlain,et al.  Salvage Chemotherapy with Taxol for Recurrent Anaplastic Astrocytomas , 1999, Journal of Neuro-Oncology.

[38]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.

[39]  C. Magee,et al.  Local Intracerebral Administration of Paclitaxel with the Paclimer® Delivery System: Toxicity Study in a Canine Model , 2005, Journal of Neuro-Oncology.

[40]  M. Johnston,et al.  A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. , 2007, Biomaterials.

[41]  Chi‐Hwa Wang,et al.  Electrohydrodynamic atomization for biodegradable polymeric particle production. , 2006, Journal of colloid and interface science.

[42]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. , 1995, Lancet.

[43]  R. Tamargo,et al.  Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. , 1993, Cancer research.

[44]  Susan M. Chang,et al.  A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants , 2001, Cancer.